The vow never to treat SRMs may seem hard to believe and self-defeating.
A new immunoassay appears to be a valid screening method for the early detection of kidney cancer.
Partial nephrectomy may lead to better overall survival and fewer health problems after surgery in patients with kidney tumors.
Bone metastases shorten progression-free and overall survival, study finds.
Compared with radical nephrectomy, nephron-sparing surgery shift serum creatinine downward.
Study demonstrates improved disease-specific and overall survival.
Male gender and older age found to be significantly associated with chronic kidney disease before and surgery.
Only 2% of patients receive it after transurethral resection of bladder tumors, despite guideline recommendations.
New findings have implications for preoperative patient counseling.
Study finds a 1.6 times increased risk, but no association with complications after radical cystectomy or prostatectomy.
Hispanics are 20% less likely to undergo the procedure than whites.
The harms of nephrectomy, however, need to be weighed against the marginal survival benefit for some patients.
Cancer-specific and the cancer-free survival rates were 99% at three and five years.
Risk is threefold greater when compared with partial nephrectomy.
It is associated with a high technical success rate and a low rate of complications; local recurrence rare.
After a median follow-up of 36 months, 98% of patients had no recurrence of small renal tumors.
Communication between the urologist and pathologist is key to arriving at the correct diagnosis, researcher says.
Regardless of overall body weight, patients with these additional criteria share a poor prognosis.